pGALSc104(G217S) Citations (1)

Originally described in: Dominant gain-of-function mutations in Hsp104p reveal crucial roles for the middle region.
Schirmer EC, Homann OR, Kowal AS, Lindquist S Mol Biol Cell 2004 May;15(5):2061-72. Epub 2004 Feb 20. PubMed Journal

---

Articles Citing pGALSc104(G217S)

Articles
KRAS and HRAS mutations confer resistance to MET targeting in preclinical models of MET-expressing tumor cells. Leiser D, Medova M, Mikami K, Nisa L, Stroka D, Blaukat A, Bladt F, Aebersold DM, Zimmer Y. Mol Oncol. 2015 Apr 14. pii: S1574-7891(15)00089-7. doi: 10.1016/j.molonc.2015.04.001. PubMed

If you have published an article using this material, please email us at to have your article added to this page.